Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Prostatic Neoplasms 2Delirium 2Thrombocytopenia 1Stomatitis 1Pleural Effusion 1Pelvic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Cyst 1Ovarian Neoplasms 1Otolaryngeal Cancer 1Metabolic Diseases 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hemostatic Disorders 1Head and Neck Neoplasms 1Emergence Delirium 1Chemotherapy-Related Cognitive Impairment 1Anemia, Aplastic 1

Interventions

vandetanib 1Tenecteplase 1Surgical Procedures, Operative 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Naproxen 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pleural Effusion × Saline Solution × Clear all
NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡